ELISA Test for Autoantibodies to deltaNp63alpha in Head and Neck Squamous Cell Carcinoma.

Gallai, Haifa.

2017-04-14T13:34:02.246Z

Description
  • Abstract: Specific Aims: To determine the autoantibody titer and percentage of head and neck squamous cell carcinoma (HNSCC) patients who have IgG and IgA serum autoantibodies to deltaNp63alpha that are detectable by Enzyme-Linked ImmunoSorbent Assay (ELISA). These results will contribute in providing an easy to administer and economical test for screening; monitoring response to treatment; obtain... read more
This object is in collection Corporate name Permanent URL
ID:
8g84n0350
To Cite:
DCA Citation Guide    EndNote